Homology Medicines Inc
Change company Symbol lookup
Select an option...
FIXX Homology Medicines Inc
HTGC Hercules Capital Inc
MPW Medical Properties Trust Inc
ST Sensata Technologies Holding PLC
ZTS Zoetis Inc
AZZ AZZ Inc
CRM Salesforce Inc
IVR-C Invesco Mortgage Capital Inc
MSM MSC Industrial Direct Co Inc
BLUE bluebird bio Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Company’s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of patients with PKU, and HMI-203, which is an investigational gene therapy candidate in clinical development for the treatment of patients with mucopolysaccharidosis type II (MPS II), or Hunter syndrome. Additionally, the Company is developing a gene therapy candidate, HMI-104, from its GTx-mAb platform for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), and conducting research in other diseases, including metachromatic leukodystrophy (MLD). Its platform is designed to utilize human hematopoietic stem cell derived adeno-associated virus vectors.

Closing Price
$1.93
Day's Change
0.10 (5.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.01
Day's Low
1.81
Volume
(Light)
Volume:
212,926

10-day average volume:
747,336
212,926
  • Prev Close
    1.83
  • Today's Open
    1.83
  • Day's Range
    1.81-2.01
  • Avg Vol (10-day)
    747.3K
  • Last (time)
    4:00p ET 07/05/22
  • Last (size)
    1.0K
  • 52-Wk Range
    1.30 - 8.90
    LowHigh
  • (09/24/21 - 05/25/22)
    48.46%
  • 91.5%
  • Market Cap
    110.8M
  • Shares Outstanding
    57.4M
  • -0.07
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.5
  • 60.94
  • (% of float 06/15/22)
    4.55

Latest News

July 05, 2022
8:30 am ET
Globe Newswire
June 29, 2022
8:00 am ET
Globe Newswire
June 28, 2022
8:39 pm ET
Accesswire
June 13, 2022
8:35 am ET
Globe Newswire
June 06, 2022
11:56 am ET
Globe Newswire
May 24, 2022
3:19 pm ET
Newsfile
1:44 pm ET
PR Newswire
1:05 pm ET
Accesswire
1:04 pm ET
Newsfile
10:54 am ET
PR Newswire
10:01 am ET
Newsfile
9:13 am ET
Newsfile
8:16 am ET
Newsfile
5:45 am ET
PR Newswire
May 23, 2022
9:00 pm ET
Globe Newswire
7:54 pm ET
Newsfile
6:08 pm ET
Newsfile
3:11 pm ET
Newsfile
1:32 pm ET
PR Newswire
12:31 pm ET
Newsfile
11:00 am ET
BusinessWire
9:58 am ET
Newsfile
8:12 am ET
Newsfile
7:59 am ET
Newsfile
6:16 am ET
Newsfile
5:45 am ET
PR Newswire
May 22, 2022
4:11 pm ET
Accesswire
May 21, 2022
4:26 pm ET
Newsfile
1:30 pm ET
Globe Newswire
May 20, 2022
11:56 pm ET
Accesswire
9:00 pm ET
BusinessWire
6:50 pm ET
Newsfile
5:15 pm ET
Globe Newswire
4:38 pm ET
Globe Newswire
3:51 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.